Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1732-1740, September 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirshaut, Y.
Right arrow Articles by Perry, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirshaut, Y.
Right arrow Articles by Perry, S.

The Use of Long-Term Human Leukocyte Cell Cultures as Models for the Study of Antileukemic Agents

Yashar Hirshaut1, George H. Weiss2 and Seymour Perry3

National Cancer Institute, NIH, Bethesda, Maryland 20014

3 Reprint requests to: Dr. Seymour Perry, National Cancer Institute, Building 10, Room 6B17, Bethesda, Maryland 20014.

Four clinically active antileukemic drugs were applied to six long-term human leukocyte cultures, derived from patients with acute and chronic myelogenous leukemia, lymphosarcoma, and Burkitt's lymphoma, to a cell line isolated from the peripheral blood of a normal individual and to a line prepared from ascitic lymphocytes of L1210 mouse leukemia. Dose-response and cell exposure time-response curves were obtained in vitro for each of the cytotoxic test agents. These studies provide new insight into the C x T relationships of the four test drugs and indicate that the long-term human leukocyte culture model may be useful in the evaluation of some of the factors determining the effectiveness of a drug as a chemotherapeutic agent.

1 Present address: Sloan-Kettering Institute for Cancer Research, New York, New York.

2 Division of Computer Research and Technology, NIH, Bethesda, Maryland.

Received 9/26/68. Accepted 5/13/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.